Calceolarioside B (Standard)

Calceolarioside B (Standard) is the analytical standard of Calceolarioside B (HY-N0539) . This product is intended for research and analytical applications. Calceolarioside B is a phenylethanoid glycoside. Calceolarioside B can be isolated from the leaves of Akebia quinata. Calceolarioside B inhibits RLAR activity with an IC50 value of 23.99 μM. Calceolarioside B inhibits the entry of Omicron BA.2 into host cells. Calceolarioside B reduces IL-6 levels. Calceolarioside B has immunomodulatory activity. Calceolarioside B has anticancer activity against human hormone-independent prostate cancer[1][2][3][4].

Product Specifications

CAS Number

[105471-98-5]

UNSPSC

12352005

Target

Aldose Reductase; Interleukin Related; Reference Standards; SARS-CoV

Type

Reference Standards

Related Pathways

Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; Others

Field of Research

Cancer; Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/calceolarioside-b-standard.html

Smiles

O[C@H]([C@@H](O)[C@@H]1O)[C@@H](O[C@@H]1COC(/C=C/C2=CC(O)=C(O)C=C2)=O)OCCC3=CC(O)=C(O)C=C3

Molecular Formula

C23H26O11

Molecular Weight

478.45

References & Citations

[1]Hwang SH, et al. Inhibitory Activities of Stauntonia hexaphylla Leaf Constituents on Rat Lens Aldose Reductase and Formation of Advanced Glycation End Products and Antioxidant. Biomed Res Int. 2017;2017:4273257.